Literature DB >> 26507172

Legal changes to increase access to naloxone for opioid overdose reversal in the United States.

Corey S Davis1, Derek Carr2.   

Abstract

BACKGROUND: Opioid overdose, which has reached epidemic levels in the United States, is reversible by administration of the medication naloxone. Naloxone requires a prescription but is not a controlled substance and has no abuse potential. In the last half-decade, the majority of states have modified their laws to increase layperson access to the medication.
METHODS: We utilized a structured legal research protocol to systematically identify and review all statutes and regulations related to layperson naloxone access in the United States that had been adopted as of September, 2015. Each law discovered via this process was reviewed and coded by two trained legal researchers.
RESULTS: As of September, 2015, 43 states and the District of Columbia have passed laws intended to increase layperson naloxone access. We categorized these laws into three domains: (1) laws intended to increase naloxone prescribing and distribution, (2) laws intended to increase pharmacy naloxone access, and (3) laws intended to encourage overdose witnesses to summon emergency responders. These laws vary greatly across states in such characteristics as the types of individuals who can receive a prescription for naloxone, whether laypeople can dispense the medication, and immunity provided to those who prescribe, dispense and administer naloxone or report an overdose emergency.
CONCLUSIONS: Most states have now passed laws intended to increase layperson access to naloxone. While these laws will likely reduce overdose morbidity and mortality, the cost of naloxone and its prescription status remain barriers to more widespread access.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Law; Naloxone; Opioids; Overdose; Public health

Mesh:

Substances:

Year:  2015        PMID: 26507172     DOI: 10.1016/j.drugalcdep.2015.10.013

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  48 in total

1.  Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.

Authors:  Amy Bachyrycz; Shikhar Shrestha; Barry E Bleske; Dale Tinker; Ludmila N Bakhireva
Journal:  Subst Abus       Date:  2016-05-10       Impact factor: 3.716

2.  Why are some people who have received overdose education and naloxone reticent to call Emergency Medical Services in the event of overdose?

Authors:  Stephen Koester; Shane R Mueller; Lisa Raville; Sig Langegger; Ingrid A Binswanger
Journal:  Int J Drug Policy       Date:  2017-07-19

3.  Increasing Access to Naloxone and Legal Issues.

Authors:  Michael Gabay
Journal:  Hosp Pharm       Date:  2016-09

4.  The changing landscape of naloxone availability in the United States, 2011 - 2017.

Authors:  Patricia R Freeman; Emily R Hankosky; Michelle R Lofwall; Jeffery C Talbert
Journal:  Drug Alcohol Depend       Date:  2018-08-30       Impact factor: 4.492

5.  Association between state Medicaid expansion status and naloxone prescription dispensing.

Authors:  Minji Sohn; Jeffery C Talbert; Chris Delcher; Emily R Hankosky; Michelle R Lofwall; Patricia R Freeman
Journal:  Health Serv Res       Date:  2020-02-07       Impact factor: 3.402

6.  Laws Mandating Coprescription of Naloxone and Their Impact on Naloxone Prescription in Five US States, 2014-2018.

Authors:  Traci C Green; Corey Davis; Ziming Xuan; Alexander Y Walley; Jeffrey Bratberg
Journal:  Am J Public Health       Date:  2020-04-16       Impact factor: 9.308

7.  Assessing Spatial Relationships between Prescription Drugs, Race, and Overdose in New York State from 2013 to 2015.

Authors:  Phillip L Marotta; Tim Hunt; Louisa Gilbert; Elwin Wu; Dawn Goddard-Eckrich; Nabila El-Bassel
Journal:  J Psychoactive Drugs       Date:  2019-05-05

8.  Association Between State Laws Facilitating Pharmacy Distribution of Naloxone and Risk of Fatal Overdose.

Authors:  Rahi Abouk; Rosalie Liccardo Pacula; David Powell
Journal:  JAMA Intern Med       Date:  2019-06-01       Impact factor: 21.873

9.  Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.

Authors:  Jennifer Miles; Jason Howell; Dave Sheridan; George Braucht; Amy Mericle
Journal:  Am J Drug Alcohol Abuse       Date:  2020-02-24       Impact factor: 3.829

10.  Descriptive Epidemiology for Community-wide Naloxone Administration by Police Officers and Firefighters Responding to Opioid Overdose.

Authors:  Sarah Cercone Heavey; Alan M Delmerico; Gale Burstein; Cheryll Moore; William F Wieczorek; R Lorraine Collins; Yu-Ping Chang; Gregory G Homish
Journal:  J Community Health       Date:  2018-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.